Skip to main content
    R

    Regencell Bioscience Holdings Ltd (RGC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $5.27
    +0.00 (+0.00%)

    Market Cap: $2.69B

    Last updated: Nov 06, 2026 at 4:33 PM ET

    Earnings

    Last 12 of 17 reported quarters
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Sep 26
    Reported Oct 28
    		$N/AN/A-N/ABeat---
    Mar 26
    Reported Jun 15
    		$N/AN/A-N/ABeat---
    Sep 25
    Reported Oct 24
    		$0.00$0.00-N/ABeat--+100.0%
    Jun 25
    Reported Jul 16
    		$N/AN/A-N/ABeat---
    Mar 25
    Reported Jun 26
    		$0.00$0.00-N/ABeat--+100.0%
    Sep 24
    Reported Oct 25
    		$0.00$0.00-N/ABeat--+100.0%
    Sep 22
    Reported Oct 31
    		$-0.30$0.00-N/AMiss---492.9%
    Mar 22
    Reported Jun 2
    		$-0.29$0.00-N/AMiss---1636.5%
    Sep 21
    Reported Oct 29
    		$-0.11$0.00-N/AMiss---558.7%
    Mar 21
    Reported Apr 26
    		$-33.38$0.00-N/AMiss---129783.3%
    Dec 20
    Reported Mar 31
    		$-0.05$0.00-N/AMiss---96.9%
    Sep 20
    Reported Dec 31
    		$-0.02$0.00-N/AMiss---12.1%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-128.50%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio10.77xQuick Ratio10.77x
    Trading Statistics
    Beta1.71Avg Volume390.54K
    52-Week High$69.0052-Week Low$4.51

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$6.35
    SMA 20$7.74
    SMA 50$6.85
    SMA 200$16.61
    EMA 10$6.36
    EMA 20$6.93
    EMA 50$7.24
    EMA 200$12.50

    MACD

    Line: -0.47Signal: -0.04Hist: -0.43

    ADX

    ADX: 30.7+DI: 17.5-DI: 28.7

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down96.0
    PSAR$8.83

    Bollinger Bands

    Upper Band$11.26
    Lower Band$4.22
    %B Position9104%(Upper)
    Band Width0.15

    RSI (14-Day)

    Neutral
    34.3

    Momentum Oscillators

    Stoch %K3.0
    Stoch %D2.1
    Williams %R-96.3
    ROC (10d)-31.3%
    Momentum-2.40
    CCI (20d)-116.9
    MFI (14d)36.6

    Volatility Measures

    ATR (14d)$0.92(17.5%)
    StdDev (20d)1.76
    Hist Vol145.5%(High)

    Volume Flow

    VWAP$5.28
    OBV16.7M
    AD Line-25.0M
    CMF (20d)-0.152

    Volume Metrics

    Avg Vol (20d)412.2K
    Vol Ratio0.5x
    VWMA (20d)$8.54

    Pivot Points

    R3$6.11
    R2$5.86
    R1$5.56
    Pivot Point$5.31
    S1$5.01
    S2$4.76
    S3$4.46

    Advanced Oscillators

    TSI-14.04
    Ultimate Osc26.2
    KST15.80

    Financial Data

    QuarterSep 2026Mar 2026Sep 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
    Cost of Revenue$363,704$40,839N/AN/AN/AN/AN/AN/A$769,687$769,687N/AN/A
    Gross Profit$-363,704$-40,839N/AN/AN/AN/AN/AN/A$-769,687$-769,687N/AN/A
    Operating Expenses$6.02M$5.30M$1.79M$1.98M$988,918$1,212$1,212N/AN/AN/AN/AN/A
    R&D$883,597$416,030$440,908$507,381$253,691$0$0$0$0$0$0$0
    SG&A$0$0$1.35M$1.47M$731,563$0$0$0$0$0$0$0
    Operating Income$-6,383,999$-5,340,462$-1,792,150$-1,977,835$-988,918$-1,212$-1,212N/AN/AN/AN/AN/A
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-6,383,954$-5,317,987$-1,730,600$-1,853,613$-926,807$-1,088$-1,088$0$0$0$0$0
    Income Tax Expense$0$0$0$0$57,887$0$0$0$0$0$0$0
    Net Income$-6,383,954$-5,317,987$-1,730,600$-1,853,613$-926,807$-1,117$-1,117N/AN/AN/AN/AN/A
    EBITDA$-6,020,295$-5,299,623$-1,730,600$-1,801,859$-912,473$158,000$-1,139$-1,009,360$-1,082,644$-3,398,061$-1,384,539$-4,954,925
    EBIT$-6,383,999$-5,340,462$-1,655,402$-1,853,615$-988,918$-1,212N/A$-1,155,928N/A$-4,167,748N/A$-5,029,999
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RGC

    News

    Regencell Bioscience Holdings Limited (RGC) Seasonal returns chart

    This article provides a seasonal returns chart for Regencell Bioscience Holdings Limited (RGC), showing the average monthly price return between 2021 and 2026. It also includes current stock information, financial data...

    Yahoo Finance UK•10/29/26•Neutral

    Regencell Bioscience Holdings (RGC) Looks Pricey On DOJ Probe And Internal Control Concerns

    Regencell Bioscience Holdings (RGC) is facing scrutiny due to widening net losses, a lack of product-sales revenue, an adverse auditor opinion on internal controls...

    Simply Wall Street•10/26/26•Bearish

    Regencell Bioscience Holdings (RGC) Looks Pricey On DOJ Probe And Internal Control Concerns

    Regencell Bioscience Holdings (RGC) is facing scrutiny due to widening net losses, a lack of product-sales revenue, an adverse auditor opinion on internal controls...

    Simply Wall Street•10/26/26•Bearish

    Regencell (RGC) Stock Looks Rich As DOJ Probe Raises Questions

    Regencell Bioscience Holdings (RGC) stock's current price of US$7.67 appears rich, especially given a P/B ratio of 284.9x compared to an industry average of 1.8x. This premium is despite widening net losses...

    Yahoo Finance Singapore•10/25/26•Bearish

    How Investors Are Reacting To Regencell Bioscience Holdings Stock (RGC) Wider Annual Loss

    Regencell Bioscience Holdings (RGC) reported a full-year 2026 net loss of US$11.7 million with no product-sales revenue...

    Simply Wall Street•10/18/26•Bearish

    RGC Valuation and Fair Value

    P/B
    195.3x
    See GNG's fair value

    RGC Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -128.5%

    RGC Competitors

    CompanyTicker
    Soleno Therapeutics IncSLNO
    Progyny IncPGNY
    Zai Lab LtdZLAB
    Warby Parker IncWRBY
    Privia Health Group IncPRVA
    Maravai Lifesciences Holdings IncMRVI
    Beam Therapeutics IncBEAM
    Neogen CorporationNEOG

    Sector: Healthcare

    RGC Bull Case vs Bear Case

    Bear case

    • RGC beat EPS estimates in 0.0% of its last 8 reported quarters.

    RGC Earnings: Beat Rate and Next Report

    Beat rate
    0 of 8 quarters (0.0%)

    Frequently Asked Questions About RGC

    Does RGC pay dividends?

    Regencell Bioscience Holdings Ltd (RGC) does not currently pay a regular dividend.

    What is RGC's market cap?

    Regencell Bioscience Holdings Ltd (RGC) has a market capitalization of $2.69B with a current stock price of $5.27.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In